Roche

Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup
Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup
Endpoints
Roche
earnings
R&D
RG6125
Actemra
RG7155
Flag link:
Real threat to Opdivo’s small-cell chances will come from elsewhere
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Flag link:
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help
Fierce Pharma
Roche
Kadcyla
Herceptin
BRCA-mutant breast cancer
Flag link:
Roche puts up $125M to expand SQZ cell therapy pact
Roche puts up $125M to expand SQZ cell therapy pact
Fierce Biotech
Roche
SQZ Biotech
cell therapy
Flag link:
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Pfizer
Amgen
Roche
FDA
social media
biosimilars
Flag link:
Roche and Novartis Strengthen Their Presence in the MS Market
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Genentech
Roche
Ocrevus
Novartis
siponimod
FDA
MS
multiple sclerosis
Flag link:
Roche gets option to Ionis' antisense dry AMD candidate
Roche gets option to Ionis' antisense dry AMD candidate
BioCentury
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
antisense
dry age-related macular degeneration
Flag link:
Roche unveils long-term data from MS blockbuster Ocrevus
Roche unveils long-term data from MS blockbuster Ocrevus
Pharmaforum
Roche
Ocrevus
relapsing multiple sclerosis
MS
Flag link:
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels
Flag link:
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom
Xconomy
hemophilia A
FDA
Roche
Hemlibra
Flag link:
Trial shows Roche’s new flu drug helps reduce symptoms in at-risk patients
Trial shows Roche’s new flu drug helps reduce symptoms in at-risk patients
Pharmaforum
Roche
Flu
influenza
baloxavir marboxil
Flag link:
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Roche
Novartis
Xolair
Xolair pen
FDA
Flag link:
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Roche
Go Therapeutics
drug development
bispecific antibodies
Flag link:
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
Go Therapeutics
Roche
Flag link:
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Roche pays €70M upfront for Tusk’s preclinical Treg depleter
Fierce Biotech
Roche
Tusk Therapeutics
M&A
Flag link:
Tecentriq sets the bar in small-cell lung cancer
Tecentriq sets the bar in small-cell lung cancer
Biopharma Dive
Roche
Tecentriq
Small-Cell Lung Cancer
Flag link:
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
UK
Roche
Avastin
wet age-related macular degeneration
Novartis
Bayer
Flag link:
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Roche
entrectinib
Ignyta
FDA
non-small cell lung cancer
Flag link:
Roche aims to improve cancer treatments with DNA blood test
Roche aims to improve cancer treatments with DNA blood test
Pharmaforum
Roche
diagnostics
cancer
personalized medicine
solid tumors
FoundationOne Liquid
Flag link:
Roche tackles clinical trial matching challenge
Roche tackles clinical trial matching challenge
Fierce Biotech
Roche
clinical trials
patients
physicians
Flag link:

Pages